Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot PET study of transporter influence on erlotinib brain and organ distribution
2015-001593-18Phase 2Active
- Sponsor
- Medical University of Vienna
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of erlotinib (3 arms), sponsored by Medical University of Vienna. Primary endpoint: Primary pharmacokinetic PET parameters. Started Apr 2015; status: active.
02
Drugs
erlotinib
Beyond the preview
Go deeper on 2015-001593-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001593-18.